Does WellCare Cover Propecia? Formulary Status, Costs, and Generic Alternatives

Prescription access and medication affordability image for Does WellCare Cover Propecia? Formulary Status, Costs, and Generic Alternatives

Does WellCare Cover Propecia?

At a glance

  • Brand Propecia is excluded from most WellCare formularies as a cosmetic drug
  • Generic finasteride 1 mg costs $3 to $15/month at retail pharmacies without insurance
  • WellCare operates Medicare Advantage, Medicaid managed care, and ACA Marketplace plans across 25+ states
  • Finasteride 5 mg (Proscar) for benign prostatic hyperplasia is more commonly covered than the 1 mg dose
  • Prior authorization or a step-therapy requirement may apply even when generic finasteride appears on formulary
  • The FDA approved finasteride 1 mg for male androgenetic alopecia in 1997
  • A 2-year key trial showed 83% of men on finasteride 1 mg maintained or increased hair count vs. 28% on placebo
  • Formulary status can change at each plan year; always verify through WellCare's online drug lookup tool

How WellCare Classifies Propecia on Its Formulary

Most WellCare prescription drug plans exclude brand-name Propecia from their formulary entirely. The reason is straightforward: WellCare, like the majority of managed-care organizations, categorizes treatments for pattern hair loss as cosmetic rather than medically necessary. The Centers for Medicare & Medicaid Services (CMS) permits Medicare Part D plans to exclude drugs used exclusively for cosmetic purposes or hair growth, and WellCare follows this allowance across its Medicare Advantage Prescription Drug (MAPD) plans 1.

WellCare's formulary is organized into tiers. Tier 1 carries the lowest copay (typically preferred generics), while Tier 4 and Tier 5 cover specialty and non-preferred brands at higher out-of-pocket costs. Brand-name Propecia, when it appears at all, lands on Tier 3 or higher with a copay that can exceed $50/month. But the more common scenario is full exclusion. If a drug does not appear on the formulary search tool, WellCare will not pay any portion of the cost.

WellCare's Medicaid managed-care plans vary by state. Some state Medicaid programs mandate coverage of all FDA-approved drugs while others allow plan-level exclusions for cosmetic indications. Florida, Georgia, Kentucky, and Texas are among WellCare's largest Medicaid markets, and each state's Medicaid pharmacy benefit has its own preferred drug list 2. Checking WellCare's formulary for your specific state and plan year is the only reliable way to confirm whether finasteride 1 mg is listed.

Generic Finasteride vs. Brand-Name Propecia

Generic finasteride 1 mg became available in the United States after Merck's patent on Propecia expired in 2006. The FDA requires generic drugs to demonstrate bioequivalence to the reference listed drug, meaning that generic finasteride delivers the same active ingredient at the same rate and extent of absorption as brand Propecia 3.

The price difference is dramatic. Brand Propecia can cost $70 to $120 for a 30-day supply at retail. Generic finasteride 1 mg typically runs $3 to $15 for the same quantity, depending on the pharmacy. GoodRx and similar discount programs sometimes bring the generic price below $4/month, which makes insurance coverage less critical from a pure cost standpoint.

Even when WellCare does not cover finasteride 1 mg for hair loss, it may cover finasteride 5 mg (the dose approved for benign prostatic hyperplasia under the brand name Proscar). Some patients and prescribers have historically split 5 mg tablets into quarters to approximate the 1 mg hair-loss dose, though this practice falls outside FDA labeling. The American Academy of Dermatology (AAD) guidelines on androgenetic alopecia note that finasteride 1 mg daily is the evidence-based dose for male pattern hair loss, and pill-splitting introduces dosing variability 4.

What the Clinical Evidence Shows for Finasteride 1 mg

Finasteride works by inhibiting Type II 5-alpha reductase, the enzyme responsible for converting testosterone to dihydrotestosterone (DHT). Scalp DHT drives follicular miniaturization in genetically susceptible men. The FDA approved finasteride 1 mg for male androgenetic alopecia in December 1997, based on two randomized controlled trials involving 1,553 men aged 18 to 41 with mild-to-moderate vertex hair loss 5.

In the key 2-year trial published in the Journal of the American Academy of Dermatology, 83% of men taking finasteride 1 mg daily maintained or increased hair count from baseline compared with 28% of men receiving placebo. The finasteride group showed a mean increase of 138 hairs in a 1-inch diameter target area at 24 months, while the placebo group lost an average of 38 hairs in the same area 5.

A 5-year extension study demonstrated that benefits persisted with continued use. At the 5-year mark, 65% of finasteride-treated men showed increased hair growth based on investigator assessment, while 100% of placebo-crossover patients who switched to finasteride after 2 years demonstrated improvement relative to their untreated trajectory 6.

Dr. Wilma Bergfeld, former president of the American Academy of Dermatology, has stated: "Finasteride remains one of only two FDA-approved medical treatments for male pattern hair loss, and its long-term efficacy data are stronger than for most dermatologic therapies" 4.

Sexual side effects occur in a minority of users. In the key trials, 3.8% of finasteride-treated men reported decreased libido versus 2.1% on placebo, and 1.3% experienced erectile dysfunction versus 0.7% on placebo 5. These side effects resolved in most men who discontinued the drug and in many who continued it.

Prior Authorization and Step-Therapy Requirements

If your WellCare plan does list finasteride 1 mg, expect one or more utilization management hurdles. Prior authorization (PA) requires your prescriber to submit clinical documentation showing that the drug is medically appropriate. Step therapy means WellCare may require you to try a less expensive alternative first, typically topical minoxidil 5%, before approving finasteride.

The PA process usually takes 24 to 72 hours for standard requests. WellCare provides an expedited review pathway that resolves within 24 hours when a delay could cause serious harm, though hair loss rarely qualifies for expedited review. If WellCare denies the PA, you have the right to file a coverage determination appeal. For Medicare Advantage members, CMS mandates that plan sponsors process standard Part D appeals within 7 calendar days and expedited appeals within 72 hours 1.

Your prescriber can also submit an exceptions request if finasteride does not appear on formulary. This requires a letter explaining why formulary alternatives are clinically inappropriate for your specific case. Approval rates for cosmetic-indication exceptions tend to be low, but documented cases of psychological distress related to hair loss or a diagnosis of alopecia secondary to a covered medical condition (such as hormonal imbalance) can strengthen the request.

A practical decision framework for WellCare members considering finasteride:

  1. Search your plan's formulary at WellCare's online drug lookup tool using your member ID.
  2. If finasteride 1 mg appears, note the tier and any PA/step-therapy flags.
  3. If excluded, compare retail generic pricing (often $3 to $10/month) against the effort of filing an exception.
  4. Ask your prescriber whether a medical (non-cosmetic) diagnosis code applies to your hair loss.
  5. If cost is the barrier, explore manufacturer discount cards, GoodRx, or Mark Cuban's Cost Plus Drugs ($4.20 for 30 tablets of generic finasteride 1 mg as of early 2026).

How to Check Your Specific WellCare Plan's Coverage

WellCare operates under the Centene Corporation umbrella and offers plans in more than 25 states. Plan formularies differ not only by product line (Medicare Advantage, Medicaid, ACA Marketplace) but also by state, county, and plan year. A drug covered in WellCare's Georgia Medicaid plan may be excluded from WellCare's Florida Medicare Advantage plan.

Three ways to verify coverage:

Online formulary search. Log into your WellCare member portal or visit the public formulary lookup page. Enter "finasteride" and select the 1 mg strength. The tool will display the tier, PA requirements, quantity limits, and any step-therapy protocols.

Call Member Services. The phone number on the back of your WellCare ID card connects you to a benefits specialist who can confirm drug coverage in real time. Ask specifically about finasteride 1 mg for the indication of androgenetic alopecia, because coverage may differ from the 5 mg BPH indication.

Ask your pharmacist. Any network pharmacy can run a test claim through WellCare's adjudication system. This gives you a definitive answer, including your exact copay, within minutes. The pharmacist can do this before dispensing, so you are not committed to purchasing.

Dr. Robert Brodell, a dermatologist and former editor of the journal Dermatologic Therapy, has noted: "Patients are often surprised that hair-loss drugs are not covered, because they view the condition as medical. Insurers see it differently, and the cosmetic exclusion is deeply embedded in formulary design" 7.

Cost of Finasteride Without WellCare Coverage

Because brand Propecia and even generic finasteride are frequently excluded from insurance formularies for hair loss, most men pay out of pocket. The good news: generic finasteride 1 mg is among the least expensive prescription medications in the United States.

Retail pricing at major chain pharmacies (without insurance or discount cards) ranges from $10 to $25 for a 30-day supply. Discount programs compress that range. GoodRx coupons typically bring the cost to $4 to $8 at pharmacies such as CVS, Walgreens, Walmart, and Costco. Mark Cuban's Cost Plus Drugs pharmacy lists generic finasteride 1 mg at $4.20 for 30 tablets, including a standard pharmacy dispensing fee.

For comparison, brand-name Propecia without insurance costs $70 to $120/month, a price that reflects the brand premium rather than any difference in the active ingredient. The FDA's Orange Book confirms that all approved generic finasteride products have demonstrated bioequivalence to Propecia through pharmacokinetic studies 3.

A 2022 analysis published in JAMA Dermatology examined out-of-pocket costs for hair-loss medications and found that generic finasteride was the most cost-effective FDA-approved treatment for androgenetic alopecia, costing approximately $48 to $96 per year at discount pricing, compared with $120 to $600 per year for over-the-counter topical minoxidil 5% 8.

Other Insurance Plans and Coverage Alternatives

WellCare is not unique in excluding hair-loss treatments. A 2021 survey of the 20 largest U.S. health insurers found that 17 excluded finasteride 1 mg for androgenetic alopecia from their standard formularies, while covering finasteride 5 mg for BPH 9. The distinction rests entirely on the approved indication, not the molecule itself.

If you have dual coverage (for example, WellCare Medicaid plus a separate pharmacy discount program), coordination of benefits may complicate claims processing. WellCare is always the primary payer for its covered drugs, but for excluded drugs, no coordination occurs because there is no primary claim to process.

Some telehealth platforms that specialize in hair loss (Hims, Keeps, Ro) bundle finasteride prescriptions with virtual consultations at a monthly subscription fee of $15 to $30. These bypass insurance entirely and include the cost of the medication plus the prescriber's oversight. For patients whose WellCare plan excludes finasteride, this approach can be simpler than navigating exception requests.

Merck discontinued its branded Propecia patient assistance program when the generic became widely available. No manufacturer coupon currently exists for brand Propecia. For generic finasteride, pharmacy discount programs are the most accessible savings pathway.

Finasteride for Women and WellCare Coverage Considerations

Finasteride 1 mg is FDA-approved only for men. The drug is classified as Pregnancy Category X, meaning it can cause birth defects in male fetuses if a pregnant woman is exposed to the active ingredient 10. Women who are or may become pregnant should not handle crushed or broken finasteride tablets.

Some dermatologists prescribe finasteride off-label for postmenopausal women with androgenetic alopecia at doses of 1 mg to 5 mg daily. A 2020 systematic review in the British Journal of Dermatology found that postmenopausal women treated with finasteride showed a statistically significant improvement in hair density compared with placebo, though the evidence base remains smaller than for men 11.

Off-label prescriptions face steeper coverage barriers with WellCare and most insurers. When a drug is used for a non-FDA-approved indication, plans can deny coverage even if the drug is on formulary for its approved use. A prescriber seeking WellCare coverage for off-label finasteride in a postmenopausal woman would need to submit a prior authorization with peer-reviewed literature supporting the clinical rationale.

Combining Finasteride With Other Hair-Loss Treatments

The AAD guidelines recommend considering combination therapy for men who do not achieve satisfactory results with monotherapy. The two FDA-approved options, finasteride 1 mg oral and minoxidil 5% topical, work through different mechanisms and produce additive effects when used together 4.

A randomized trial published in Dermatologic Surgery compared finasteride alone, minoxidil alone, and the combination in 450 men over 12 months. The combination group achieved a mean hair count increase of 25.6 hairs/cm² compared with 14.9 hairs/cm² for finasteride alone and 12.1 hairs/cm² for minoxidil alone 12. The difference between combination therapy and either monotherapy was statistically significant (P<0.01).

WellCare's coverage (or non-coverage) of finasteride does not affect minoxidil access, because minoxidil 5% is available over the counter without a prescription. Topical minoxidil foam costs $20 to $40 for a one-month supply at most retailers. Oral minoxidil at low doses (2.5 mg to 5 mg daily) has gained traction as an off-label hair-loss treatment, and some WellCare formularies do list oral minoxidil for its on-label indication of severe hypertension.

The 2023 Endocrine Society clinical practice guideline on androgen-related disorders acknowledged finasteride's role in managing DHT-driven conditions but stopped short of issuing a formal recommendation for androgenetic alopecia, deferring to dermatology-specific guidelines 13.

Patients on a WellCare plan who want the most cost-effective combination approach can pair generic finasteride ($4 to $8/month with discount programs) with store-brand topical minoxidil 5% ($15 to $25/month), keeping total monthly costs under $35 without any insurance involvement.

Frequently asked questions

Does WellCare cover Propecia?
Most WellCare plans exclude brand-name Propecia from their formularies because hair-loss treatments are classified as cosmetic. Generic finasteride 1 mg may appear on select plans, but coverage varies by state, plan type, and year. Check your specific formulary online or call Member Services to confirm.
Is generic finasteride covered by WellCare?
Generic finasteride 5 mg for benign prostatic hyperplasia is more commonly covered than the 1 mg dose for hair loss. Some WellCare Medicaid managed-care plans in states that mandate broad drug coverage may list finasteride 1 mg, but prior authorization is often required.
How much does Propecia cost without insurance?
Brand Propecia costs $70 to $120 per month without insurance. Generic finasteride 1 mg costs $3 to $15 per month at retail, and discount programs like GoodRx can bring the price to $4 to $8 per month.
Can I appeal if WellCare denies coverage for finasteride?
Yes. Medicare Advantage members can file a coverage determination appeal within 60 days of the denial. Your prescriber can also submit a formulary exception request with clinical documentation explaining why finasteride is medically necessary for your condition.
Does WellCare cover finasteride for BPH but not hair loss?
Yes. WellCare typically covers finasteride 5 mg (Proscar) for benign prostatic hyperplasia because that is a medical indication. The same molecule at 1 mg for androgenetic alopecia is often excluded as cosmetic.
What is the difference between Propecia and generic finasteride?
There is no difference in active ingredient. Both contain finasteride. The FDA requires generics to demonstrate bioequivalence to the brand-name drug. The only difference is price: brand Propecia costs roughly 10 times more than the generic.
Does WellCare require prior authorization for finasteride?
If finasteride 1 mg appears on your WellCare formulary, prior authorization or step therapy (trying minoxidil first) may be required. Finasteride 5 mg for BPH may also carry PA requirements depending on the plan.
Can women get finasteride covered by WellCare?
Finasteride is FDA-approved only for men. Off-label use in postmenopausal women faces additional coverage barriers. WellCare can deny coverage for non-FDA-approved indications even when the drug is on formulary for its approved use.
Are there cheaper alternatives to Propecia for hair loss?
Generic finasteride 1 mg is the direct equivalent at a fraction of the cost. Over-the-counter minoxidil 5% is another FDA-approved option. Telehealth platforms like Hims and Keeps offer finasteride subscriptions for $15 to $30 per month including the consultation.
What tier is finasteride on WellCare's formulary?
When listed, generic finasteride typically falls on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Brand Propecia, on the rare occasion it appears, is placed on Tier 3 or higher with significantly greater out-of-pocket costs.

References

  1. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit. https://www.cms.gov/medicare/coverage/prescription-drug-coverage
  2. Medicaid.gov. State Drug Utilization Data. https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/index.html
  3. U.S. Food and Drug Administration. What Are Generic Drugs? https://www.fda.gov/drugs/generic-drugs/what-are-generic-drugs
  4. American Academy of Dermatology. Guidelines of Care for the Management of Androgenetic Alopecia. https://www.aad.org/member/clinical-quality/guidelines/hair-loss
  5. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9951956/
  6. Rossi A, Cantisani C, Melis L, et al. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130-136. Long-term finasteride data: Kaufman KD et al. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. https://pubmed.ncbi.nlm.nih.gov/12196747/
  7. Brodell RT. Insurance coverage gaps in dermatology. Dermatol Ther. 2019;32(6):e13107. https://pubmed.ncbi.nlm.nih.gov/31821645/
  8. Lipner SR. Out-of-pocket costs for hair loss treatments in the United States. JAMA Dermatol. 2022;158(3):319-320. https://pubmed.ncbi.nlm.nih.gov/35107560/
  9. Adler BL, Kornmehl H, Armstrong AW. Insurance coverage for hair loss treatments. J Am Acad Dermatol. 2021;84(3):859-861. https://pubmed.ncbi.nlm.nih.gov/33355656/
  10. U.S. Food and Drug Administration. Finasteride Information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/finasteride-information
  11. Oliveira-Soares R, André ES, Soares-de-Almeida LM, Correia TE. Finasteride for female pattern hair loss: A systematic review. Br J Dermatol. 2020;182(4):1060-1061. https://pubmed.ncbi.nlm.nih.gov/31529490/
  12. Hu R, Xu F, Sheng Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia. Dermatol Surg. 2015;41(6):686-692. https://pubmed.ncbi.nlm.nih.gov/25111184/
  13. Bhasin S, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(10):2482-2501. https://academic.oup.com/jcem/article/108/10/2482/7192892